Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug–drug interaction study of TS-172 with triazolam and itraconazole in healthy adult males
jRCT2071240112Phase 1Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of TS-172 in hyperphosphatemia (2 arms), sponsored by Taisho Pharmaceutical. Primary endpoint: Drug concentration in plasma. Started Mar 2025; status: completed.
02
Drugs
TS-172
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on jRCT2071240112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240112.